LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
30.63
-0.75 (-2.39%)
Apr 29, 2026, 9:32 AM EDT - Market open
LB Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 878 | 563 | - | - | - |
| Enterprise Value | 608 | 252 | - | - | - |
| Last Close Price | 31.38 | 22.26 | - | - | - |
| PB Ratio | 2.63 | 1.87 | - | - | - |
| P/TBV Ratio | 2.99 | 1.87 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.19 | - | -1.12 |
| Net Debt / Equity Ratio | -0.97 | -0.97 | -1.23 | -1.04 | -0.13 |
| Net Debt / EBITDA Ratio | 9.99 | 9.99 | 0.38 | 3.81 | -0.98 |
| Net Debt / FCF Ratio | 8.27 | 8.27 | 0.45 | 3.57 | -1.01 |
| Quick Ratio | 39.67 | 39.67 | 3.45 | 16.61 | 45.64 |
| Current Ratio | 41.45 | 41.45 | 3.56 | 17.51 | 45.82 |
| Return on Equity (ROE) | -15.70% | -15.70% | -206.22% | -63.14% | - |
| Return on Assets (ROA) | -10.64% | -10.64% | -102.33% | -21.18% | - |
| Return on Capital Employed (ROCE) | -9.70% | -9.70% | -255.00% | -26.40% | -13.40% |
| Earnings Yield | -2.80% | -4.48% | - | - | - |
| FCF Yield | -3.92% | -6.26% | - | - | - |
| Buyback Yield / Dilution | -2145.81% | -2145.81% | -43.52% | -8.02% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.